Cost Savings in CKD Screening Using MATLOC

Chronic Kidney Disease (CKD) affects over 120 million individuals in North America, yet fewer than 50% of at-risk patients are screened. The MATLOC point-of-care (POC) device is designed to reverse this trend by offering lab-equivalent results at a fraction of the cost—at the point of care. Early screening with MATLOC enables earlier diagnosis, faster intervention, and significant downstream savings for both healthcare providers and payers.